menu
    • menu

    Company profile for Optimi Health

    NEW Drugs in Dev: 3
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Optimi Health is preparing to launch its business through the construction of two purpose-built 10,000 sq. ft. facilities in British Columbia. Once operational, these facilities will be dedicated to cultivation, processing and agronomic excellence. Optimi has invested time, capital and professional resources into the future of human optimization.Optimi will cultivate, extract, process, package and ship the finest strains of fu...
    Optimi Health is preparing to launch its business through the construction of two purpose-built 10,000 sq. ft. facilities in British Columbia. Once operational, these facilities will be dedicated to cultivation, processing and agronomic excellence. Optimi has invested time, capital and professional resources into the future of human optimization.Optimi will cultivate, extract, process, package and ship the finest strains of functional mushrooms from it’s two purpose-built, GMP-capable facilities.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Optimi HealthCanada Flag
    Country
    Country
    Canada
    Address
    Address
    201-1448 Commercial Drive Vancouver BC V5L 3X9
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.optimihealth.ca/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/optimihealth/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    SCOPE Summit

    SCOPE Summit

    Not Confirmed

    envelop Contact Supplier

    SCOPE Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Optimi Health Announces Closing of Fully Subscribed $1,500,000 Financing
    Optimi Health Announces Closing of Fully Subscribed $1,500,000 Financing

    01 Jun 2024

    // ENDPTS

    https://firstwordpharma.com/story/5862615

    ENDPTS
    01 Jun 2024
    Share Share
    Optimi Secures Import Permit For MDMA, Psilocybin From Mind Medicine
    Optimi Secures Import Permit For MDMA, Psilocybin From Mind Medicine

    29 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/29/2889834/0/en/Optimi-Health-Secures-Import-Permit-from-Mind-Medicine-Australia-for-MDMA-and-Psilocybin-Capsules.html

    GLOBENEWSWIRE
    29 May 2024
    Share Share
    Optimi, ATMA Advance MDD Trial For Group, Individual
    Optimi, ATMA Advance MDD Trial For Group, Individual

    22 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/22/2886486/0/en/Optimi-Health-ATMA-Sign-Letter-of-Intent-To-Advance-Phase-II-Clinical-Trial-Group-and-Individual-Administration-Protocol-For-Major-Depressive-Disorder.html

    GLOBENEWSWIRE
    22 May 2024
    Share Share
    Optimi Receives Analysis For GMP MDMA 40mg, 60mg Capsules
    Optimi Receives Analysis For GMP MDMA 40mg, 60mg Capsules

    14 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/14/2881341/0/en/Optimi-Health-Receives-Certificate-of-Analysis-For-MDMA-40mg-and-60mg-GMP-Capsules.html

    GLOBENEWSWIRE
    14 May 2024
    Share Share
    Optimi Health Provides Corporate Update
    Optimi Health Provides Corporate Update

    10 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/10/2879622/0/en/Optimi-Health-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    10 May 2024
    Share Share
    Optimi Gets Permit To Ship MDMA To Tel Aviv Psychedelic Institute
    Optimi Gets Permit To Ship MDMA To Tel Aviv Psychedelic Institute

    09 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/09/2878713/0/en/Optimi-Health-Receives-Export-Permit-from-Health-Canada-to-Ship-MDMA-To-Tel-Aviv-University-s-Institute-for-Psychedelic-Research.html

    GLOBENEWSWIRE
    09 May 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search